Progression of adenomyosis magnetic resonance imaging features under ulipristal acetate for symptomatic fibroids
article
OA: bronze
CC0
⤵ 5 in-corpus citations
AI-generated summary
This study investigated how magnetic resonance imaging features of adenomyosis change during ulipristal acetate treatment for symptomatic uterine fibroids.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (31)
- Diagnosing adenomyosis: an integrated clinical and imaging approach via openalex
- Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation. via openalex
- Estrogen and Progesterone Receptors of Adenomyosis in Postmenopausal Breast Cancer Patients Treated with Tamoxifen via openalex
- Four subtypes of adenomyosis assessed by magnetic resonance imaging and their specification via openalex
- Functional characterization of somatic point mutations of the human estrogen receptor α (hERα) in adenomyosis uteri via openalex
- Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis via openalex
- Histological evaluation of the prevalence of adenomyosis, myomas and of their concomitance via openalex
- Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis via openalex
- Pathogenesis of adenomyosis: an update on molecular mechanisms via openalex
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? via openalex
- Progesterone Induction of 17β-Hydroxysteroid Dehydrogenase Type 2 during the Secretory Phase Occurs in the Endometrium of Estrogen-Dependent Benign Diseases But Not in Normal Endometrium via openalex
- Promoter Hypermethylation of Progesterone Receptor Isoform B (PR-B) in Adenomyosis and Its Rectification by a Histone Deacetylase Inhibitor and a Demethylation Agent via openalex
- Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis via openalex
- Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications via openalex
- Tamoxifen‐associated postmenopausal adenomyosis exhibits stromal fibrosis, glandular dilatation and epithelial metaplasias via openalex
- Ulipristal Acetate Improves Clinical Symptoms in Women with Adenomyosis and Uterine Myomas via openalex
- Ulipristal acetate therapy increases ultrasound features of adenomyosis: a good treatment given in an erroneous diagnosis of uterine fibroids via openalex
- Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology via openalex
- Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy via openalex
- W6732527681 via openalex
- W1969068003 via openalex
- W1996100965 via openalex
- W2035633938 via openalex
- W2075217182 via openalex
- W2098707038 via openalex
- W2106587450 via openalex
- W2156957181 via openalex
- W2165109616 via openalex
- W2581546164 via openalex
- W2900558921 via openalex
- W2958075981 via openalex
Cited by (5)
- Drug development for adenomyosis based on pathophysiology 2025
- Effects of Shixiao Huoxue Decoction on pain, tumor necrosis factor-α, and interleukin-8 in patients with adenomyosis 2024
- The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review 2023
- Medical Treatment of Adenomyosis 2022
- Current and Prospective Treatment of Adenomyosis 2021
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:21:30.380497+00:00
License: CC0
· commercial use OK